In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Sarepta Therapeutics Inc (NASDAQ: SRPT) closed at $16.75 in the last session, down -2.05% from day before closing price of $17.1. In other words, the price has decreased by -$2.05 from its previous closing price. On the day, 8.03 million shares were traded. SRPT stock price reached its highest trading level at $17.4 during the session, while it also had its lowest trading level at $16.52.
Ratios:
We take a closer look at SRPT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.46 and its Current Ratio is at 4.02. In the meantime, Its Debt-to-Equity ratio is 1.18 whereas as Long-Term Debt/Eq ratio is at 1.18.
On July 29, 2025, JP Morgan Upgraded its rating to Neutral which previously was Underweight but kept the price unchanged to $24.
Barclays Upgraded its Underweight to Equal Weight on July 29, 2025, while the target price for the stock was maintained at $22.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 12 ’25 when Nicaise Claude sold 2,491 shares for $99.64 per share. The transaction valued at 248,203 led to the insider holds 27,812 shares of the business.
Nicaise Claude bought 2,491 shares of SRPT for $248,226 on Mar 12 ’25. On Dec 12 ’24, another insider, Wigzell Hans Lennart Rudolf, who serves as the Director of the company, sold 10,500 shares for $124.84 each. As a result, the insider received 1,310,820 and left with 22,840 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SRPT now has a Market Capitalization of 1646139776 and an Enterprise Value of 2480101376. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.74 while its Price-to-Book (P/B) ratio in mrq is 1.44. Its current Enterprise Value per Revenue stands at 1.11 whereas that against EBITDA is -31.694.
Stock Price History:
The Beta on a monthly basis for SRPT is 0.47, which has changed by -0.8804084 over the last 52 weeks, in comparison to a change of 0.21149921 over the same period for the S&P500. Over the past 52 weeks, SRPT has reached a high of $145.00, while it has fallen to a 52-week low of $10.41. The 50-Day Moving Average of the stock is -29.32%, while the 200-Day Moving Average is calculated to be -78.91%.
Shares Statistics:
According to the various share statistics, SRPT traded on average about 11.34M shares per day over the past 3-months and 25183270 shares per day over the past 10 days. A total of 98.25M shares are outstanding, with a floating share count of 93.47M. Insiders hold about 4.89% of the company’s shares, while institutions hold 96.44% stake in the company. Shares short for SRPT as of 1752537600 were 14856573 with a Short Ratio of 1.31, compared to 1749772800 on 9885949. Therefore, it implies a Short% of Shares Outstanding of 14856573 and a Short% of Float of 17.709999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
